HVIVO PLC LS-,001

At close
No trades
See on super-charts

Key stats

Market capitalization
108.014MEUR
Dividends yield (FY)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
−0.002EUR

About HVIVO PLC LS-,001

ISIN
GB00B9275X97
CEO
Yamin Mohammed Khan
Headquarters
London
Founded
2011

hVIVO PLC provides pharmaceutical development services. The company operates under the hVIVO and Venn Life Sciences Clinical Division. The hVIVO segment is involved in the conducting of human challenge trials and related laboratory services. The Venn Life Sciences Clinical Research Division provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. The company was founded on February 1, 2011 and is headquartered in London, the United Kingdom.

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:
‪0‬
Revenue
‪0‬

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more